MVA-PSA-PAP prostate cancer vaccine

{
  "id": "MLC-T-ONC-015384",
  "term": "MVA-PSA-PAP prostate cancer vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine consisting of a recombinant modified vaccinia Ankara (MVA) viral vector encoding genes for prostate specific antigen (PSA) and prostate acid phosphatase (PAP) with potential immunostimulatory and antineoplastic activities. Upon administration, MVA-PSA-PAP prostate cancer vaccine expresses PSA and PAP peptides, which may elicit humoral and cellular immune responses against prostate cancer cells expressing PSA and PAP. Multi-antigen vaccine therapy may be more efficacious than single-antigen therapy vaccine therapy.",
  "synonyms": [
    "modified vaccinia Ankara (Bavarian Nordic) prostate cancer vaccine",
    "MVA-BN-PRO"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/mva-psa-pap-prostate-cancer-vaccine/"
}